methamphetamine and vigabatrin

methamphetamine has been researched along with vigabatrin in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's4 (57.14)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Ashby, CR; Brodie, JD; Dewey, SL; Gardner, EL; Gerasimov, MR; Mills, MJ1
Brodie, JD; Dewey, SL; Figueroa, E; Laska, EM1
Alexoff, DL; Dewey, SL; Lee, DE; Patel, VD; Schiffer, WK1
Aquilina, SD; Brodie, JD; Dalal, RM; DeMarco, A; Dewey, SL; Hammel, C; Kahanda, M; Kothari, SK; Liebling, CN; Mullapudi, U; Pai, J; Patel, V; Schiffer, WK1
De La Garza, R; Heinzerling, KG; London, ED; Moody, DE; Newton, TF; Nusinowitz, S; Shoptaw, S; Zorick, T1

Reviews

1 review(s) available for methamphetamine and vigabatrin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

2 trial(s) available for methamphetamine and vigabatrin

ArticleYear
Safety and efficacy of gamma-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction.
    Synapse (New York, N.Y.), 2005, Volume: 55, Issue:2

    Topics: Cocaine-Related Disorders; Enzyme Inhibitors; Female; Humans; Male; Methamphetamine; Substance-Related Disorders; Treatment Outcome; Vigabatrin

2005
The cardiovascular and subjective effects of methamphetamine combined with gamma-vinyl-gamma-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteers.
    Pharmacology, biochemistry, and behavior, 2009, Volume: 94, Issue:1

    Topics: 4-Aminobutyrate Transaminase; Adult; Amphetamine-Related Disorders; Blood Pressure; Cardiovascular System; Central Nervous System Stimulants; Depression; Double-Blind Method; Female; GABA Agents; Half-Life; Heart Rate; Humans; Male; Methamphetamine; Middle Aged; Reinforcement, Psychology; Vigabatrin; Visual Fields

2009

Other Studies

4 other study(ies) available for methamphetamine and vigabatrin

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine.
    Synapse (New York, N.Y.), 1999, Volume: 34, Issue:1

    Topics: Analgesics, Opioid; Animals; Anticonvulsants; Central Nervous System Depressants; Dopamine; Dopamine Uptake Inhibitors; Ethanol; Extracellular Space; gamma-Aminobutyric Acid; Heroin; Male; Methamphetamine; Microdialysis; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Time Factors; Vigabatrin

1999
Imaging dopamine release with Positron Emission Tomography (PET) and (11)C-raclopride in freely moving animals.
    NeuroImage, 2008, Jul-01, Volume: 41, Issue:3

    Topics: Animals; Brain; Carbon Radioisotopes; Dopamine; Dopamine Agents; Dopamine Antagonists; GABA Agents; Image Processing, Computer-Assisted; Male; Methamphetamine; Movement; Positron-Emission Tomography; Raclopride; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tissue Distribution; Vigabatrin

2008
Racemic gamma vinyl-GABA (R,S-GVG) blocks methamphetamine-triggered reinstatement of conditioned place preference.
    Synapse (New York, N.Y.), 2009, Volume: 63, Issue:2

    Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Conditioning, Classical; Extinction, Psychological; GABA Agents; Isomerism; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; Recurrence; Vigabatrin

2009